Brian Anderson
Psychiatry · Louisville, CONPI 1417058496
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 407 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 407 payments — averaging $14.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$776
- Lundbeck LLC$531
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$414
- Takeda Pharmaceuticals U.S.A., Inc.$352
- Idorsia Pharmaceuticals US Inc$283
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,89399%
- Education$491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 74 | $1,196 |
| Otsuka America Pharmaceutical, Inc. | 74 | $776 |
| Lundbeck LLC | 35 | $531 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $414 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $352 |
| Idorsia Pharmaceuticals US Inc | 18 | $283 |
| Sunovion Pharmaceuticals Inc. | 23 | $279 |
| Bausch Health US, LLC | 22 | $271 |
| Corium, LLC | 17 | $269 |
| Johnson & Johnson | 6 | $213 |
| Eisai Inc. | 20 | $202 |
| Vanda Pharmaceuticals Inc. | 13 | $183 |
| E.r. Squibb & Sons, L.L.C. | 10 | $177 |
| Supernus Pharmaceuticals, Inc. | 10 | $171 |
| Noven Therapeutics, LLC | 5 | $101 |
| Vertical Pharmaceuticals, LLC | 6 | $98 |
| Tris Pharma Inc | 3 | $70 |
| Alfasigma USA, Inc. | 4 | $59 |
| Axsome Therapeutics, Inc. | 3 | $43 |
| Alkermes, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Adlon Therapeutics L.p. | 2 | $29 |
| Avanir Pharmaceuticals, Inc. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| Ironshore Pharmaceuticals Inc. | 2 | $29 |
| Almatica Pharma LLC | 2 | $27 |
| Neos Therapeutics, LP | 2 | $25 |
| Shire North American Group Inc | 1 | $12 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$137
How this compares
$5,941 in reported general payments places this provider in the 95th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 12 | $41,962 |
| Bupropion XlBupropion Hcl | 39 | $1,449 |
| Olanzapine | 26 | $1,153 |
| Aripiprazole | 36 | $1,110 |
| Methylphenidate ErMethylphenidate Hcl | 16 | $1,051 |
| Quetiapine Fumarate | 27 | $692 |
| Lamotrigine | 34 | $620 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 24 | $578 |
| Vilazodone Hcl | 15 | $567 |
| Zolpidem Tartrate ErZolpidem Tartrate | 20 | $494 |
| Duloxetine Hcl | 17 | $472 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $444 |
| Zolpidem Tartrate | 38 | $430 |
| Clonazepam | 56 | $396 |
| Escitalopram Oxalate | 28 | $210 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $213 | $41,96212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 559 psychiatry providers in Colorado.
Other psychiatry in Louisville
- David MillerLouisville$6K
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
- Charles ParkLone Tree$89K
- Cynthia EppersonAurora$64K
- Brian WiseCentennial$44K
- Robert CowanCentennial$29K
- Brenda CzabanDenver$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.